Which is better, FOLD or RO.SW?

On the Buffett-Fit framework, Roche Holding AG (RO.SW) currently grades higher than FOLD, 65/100 (B grade) vs 50/100 (C). That said, "better" depends on which framework you trust, FOLD wins on Joel Greenblatt; RO.SW wins on Warren Buffett, Benjamin Graham, Philip Fisher, Peter Lynch, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy FOLD or RO.SW?

This page is an educational comparison, not investment advice. Both FOLD and RO.SW are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most, and always do your own research before making any investment decision.

Is FOLD better than RO.SW for value investing?

On the Buffett-style value-investing framework, RO.SW currently grades higher, 65/100 vs 50/100, a 15-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between FOLD and RO.SW on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). FOLD currently scores 50/100; RO.SW scores 65/100. The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, FOLD or RO.SW?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. FOLD and RO.SW are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, FOLD or RO.SW?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are FOLD and RO.SW both Healthcare stocks?

Yes: both Amicus Therapeutics, Inc. (FOLD) and Roche Holding AG (RO.SW) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this FOLD vs RO.SW comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria: they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

RO.SW vs FOLD: 65/100 vs 50/100 on Buffett-Fit · invest-like

Stock comparison

Amicus Therapeutics

FOLD-Healthcare Market cap, Sector

Roche

RO.SW$283.49BHealthcare Market cap, Sector

Overall winner

Roche

FOLD 16 RO.SW

Based on the combined fit scores from all four strategies. The breakdown by strategy is below.

Fit scores by strategy

FOLD1wins

6winsRO.SW

Warren Buffett

50D

C65

Benjamin Graham

50D

B70

Philip Fisher

50D

D59

Peter Lynch

50D

D58

Joel Greenblatt

50D

D48

Charlie Munger

50D

B79

Terry Smith

50D

B70

Side-by-side metrics

Metric	FOLD	RO.SW
Market cap	-	$283.49B
P/E (TTM)	-	20.5x
EV/EBIT	-	15.9x
ROIC (TTM)	-	23.24%
Gross margin

More like FOLD

FOLD vs LLY FOLD vs JNJ FOLD vs ABBV FOLD vs UNH

More like RO.SW

RO.SW vs LLY RO.SW vs JNJ

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

For education only. Fit scores apply each investor's published criteria to public financial data. They are not personal recommendations.

See the full analysis of Amicus Therapeutics vs Roche

The score, the checklist and the full reasoning open with a free account. You get 3 full analyses a week, and this stock is the first one. No card needed.

Create a free account

3 full analyses a week · no card needed

Already have an account? Sign in

See the full analysis of Amicus Therapeutics vs Roche

Key terms in this analysis